Literature DB >> 20152182

CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain.

Jing Wang1, Ian C G Weaver, Andrée Gauthier-Fisher, Haoran Wang, Ling He, John Yeomans, Frederic Wondisford, David R Kaplan, Freda D Miller.   

Abstract

Increasing evidence indicates that epigenetic changes regulate cell genesis. Here, we ask about neural precursors, focusing on CREB binding protein (CBP), a histone acetyltransferase that, when haploinsufficient, causes Rubinstein-Taybi syndrome (RTS), a genetic disorder with cognitive dysfunction. We show that neonatal cbp(+/-) mice are behaviorally impaired, displaying perturbed vocalization behavior. cbp haploinsufficiency or genetic knockdown with siRNAs inhibited differentiation of embryonic cortical precursors into all three neural lineages, coincident with decreased CBP binding and histone acetylation at promoters of neuronal and glial genes. Inhibition of histone deacetylation rescued these deficits. Moreover, CBP phosphorylation by atypical protein kinase C zeta was necessary for histone acetylation at neural gene promoters and appropriate differentiation. These data support a model in which environmental cues regulate CBP activity and histone acetylation to control neural precursor competency to differentiate, and indicate that cbp haploinsufficiency disrupts this mechanism, thereby likely causing cognitive dysfunction in RTS. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152182     DOI: 10.1016/j.devcel.2009.10.023

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  69 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  An old drug for new ideas: metformin promotes adult neurogenesis and spatial memory formation.

Authors:  Matthew B Potts; Daniel A Lim
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

3.  Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin.

Authors:  Ramy Ayoub; Rebecca M Ruddy; Elizabeth Cox; Adeoye Oyefiade; Daniel Derkach; Suzanne Laughlin; Benjamin Ades-Aron; Zahra Shirzadi; Els Fieremans; Bradley J MacIntosh; Cynthia B de Medeiros; Jovanka Skocic; Eric Bouffet; Freda D Miller; Cindi M Morshead; Donald J Mabbott
Journal:  Nat Med       Date:  2020-07-27       Impact factor: 53.440

Review 4.  Acetyltransferases (HATs) as targets for neurological therapeutics.

Authors:  Anne Schneider; Snehajyoti Chatterjee; Olivier Bousiges; B Ruthrotha Selvi; Amrutha Swaminathan; Raphaelle Cassel; Frédéric Blanc; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 5.  Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease.

Authors:  Isabel Beerman; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

6.  Borna disease virus phosphoprotein modulates epigenetic signaling in neurons to control viral replication.

Authors:  Emilie M Bonnaud; Marion Szelechowski; Alexandre Bétourné; Charlotte Foret; Anne Thouard; Daniel Gonzalez-Dunia; Cécile E Malnou
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

Review 7.  Genetic syndromes caused by mutations in epigenetic genes.

Authors:  María Berdasco; Manel Esteller
Journal:  Hum Genet       Date:  2013-01-31       Impact factor: 4.132

8.  Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model.

Authors:  Ashley A Johnson; Jessica Sarthi; Sheila K Pirooznia; William Reube; Felice Elefant
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

9.  Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis.

Authors:  Ling He; Karuna Naik; Shumei Meng; Jia Cao; Aniket R Sidhaye; Anlin Ma; Sally Radovick; Fredric E Wondisford
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

Review 10.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.